Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more


pME map2k2a_s219D
(Plasmid #201058)


Item Catalog # Description Quantity Price (USD)
Plasmid 201058 Standard format: Plasmid sent in bacteria as agar stab 1 $85

This material is available to academics and nonprofits only.


  • Vector backbone
  • Backbone manufacturer
  • Backbone size w/o insert (bp) 4762
  • Total vector size (bp) 5956
  • Vector type
    Zebrafish expression

Growth in Bacteria

  • Bacterial Resistance(s)
    Kanamycin, 50 μg/mL
  • Growth Temperature
  • Growth Strain(s)
  • Copy number


  • Gene/Insert name
  • Species
    D. rerio (zebrafish)
  • Insert Size (bp)
  • Mutation
    Mutation S219D, constitutively active
  • GenBank ID
  • Entrez Gene
    map2k2a (a.k.a. fa56c06, map2k2, mek2, wu:fa56c06, zgc:123171)
  • Promoter none

Cloning Information

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
  • Zeocin® is an InvivoGen trademark.
How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pME map2k2a_s219D was a gift from Sarah Childs (Addgene plasmid # 201058 ; ; RRID:Addgene_201058)
  • For your References section:

    rasa1-related arteriovenous malformation is driven by aberrant venous signalling. Greysson-Wong J, Rode R, Ryu JR, Chan JL, Davari P, Rinker KD, Childs SJ. Development. 2023 Sep 15;150(18):dev201820. doi: 10.1242/dev.201820. Epub 2023 Sep 14. 10.1242/dev.201820 PubMed 37708300